Insulin-like Growth Factor I Receptor Antagonism Augments Response to Chemoradiation Therapy in Colon Cancer Cells

By Perer E.S.   Madan A.K.   Shurin A.   Zakris E.   Romeguera K.   Pang Y.   Beech D.J.  

Journal of Surgical Research, Vol. 94, Iss. 1, 2000-11 ,pp. : 1-5

Academic Press

Access to resources Recommend Favorite

Serum vascular endothelial growth factor is a candidate biomarker of metastatic tumor response to ex vivo gene therapy of renal cell cancer

By Baccala A.A.   Zhong H.   Clift S.M.   Nelson W.G.   Marshall F.F.   Passe T.J.   Gambill N.B.   Simons J.W.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 327-332

Elsevier

Access to resources Recommend Favorite

Quantitative Analysis of Vascular Endothelial Growth Factor in Colon Cancer

By  

European Surgical Research, Vol. 30, Iss. 4, 1998-07 ,pp. : 273-278

Karger

Access to resources Recommend Favorite

Qualitative and Quantitative Issues of Lymph Nodes as Prognostic Factor in Colon Cancer

By  

Digestive Surgery, Vol. 30, Iss. 1, 2013-04 ,pp. : 1-11

Karger

Access to resources Recommend Favorite

Expression of serum response factor (SRF) in normal and regenerating pancreas

By Fagan S.P.   Berger D.H.   Awad S.S.   Patten L.C.   Belaguli N.S.  

Journal of Surgical Research, Vol. 114, Iss. 2, 2003-10 ,pp. : 267-268

Elsevier

Access to resources Recommend Favorite